Why Trump's tariffs on India's generic drugs could cost Americans more

India's pharmaceutical industry is scrambling to assess the impact of generic drugs tariffs proposed by United States President Donald Trump. Analysts warn the measures could disrupt global drug supply chains, push up medicine prices for Americans and force Indian drugmakers to rethink their manufacturing strategies. On CNA's Asia First, Joseph Carrello, a research fellow at the Melbourne School of Population and Global Health, discusses what the proposed tariffs could mean for the pharmaceutical industry and consumers.

Subscribe to our channel here: https://cna.asia/youtubesub

Visit our website: https://cna.asia
Download our app: https://cna.asia/app

Get our editors' picks of stories via chat apps:
Telegram: https://cna.asia/telegram
WhatsApp: https://cna.asia/whatsapp

Follow us on these platforms:
https://www.facebook.com/channelnewsasia
https://www.instagram.com/channelnewsasia
https://www.tiktok.com/@channelnewsasia